Dr. Andrew Smith , MD
Allergy & Immunology • Sandy, UT
7390 S Creek Rd Ste 201
Sandy, UT 840936123
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Andrew Smith is listed in NPPES under Allergy & Immunology.
-
NPI assigned on June 21, 2006; this date does not establish years in practice.
-
Published CMS data list 15,834 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J2357 — Injection, omalizumab, 5 mg: 7,050 service units.
- 95165 — Professional service for preparation and provision of 1 or more antigens: 3,960 service units.
- 95004 — Test for allergy using allergenic extract: 1,601 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 17 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 1,562 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Montelukast Sodium — 330 prescription fills, including refills.
- Famotidine — 134 prescription fills, including refills.
- Levocetirizine Dihydrochloride — 106 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 36 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Allergy & Immunology in Utah (2024, 17 clinicians with data). Median for this group: 502. Middle half: 257 to 1,276.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 5,974 in 2020 to 15,834 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
7390 S Creek Rd Ste 201
Sandy, UT 840936123
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Allergy Associates Of Utah Pc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Northwestern University Feinberg Medical School
2001
What Public CMS Data Show
Allergy & Immunology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
282 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $398,210 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $307,209 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
2,356 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$523,381 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $146,097.99 across 323 records.
By nature of payment (3 largest of 5)
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $90,141.50 across 47 records.
- Consulting Fee: $31,147.22 across 11 records.
- Travel and Lodging: $18,489.42 across 64 records.
Reporting-company totals (3 largest of 31)
- AstraZeneca Pharmaceuticals LP: $97,628.33 across 135 records.
- Pharming Healthcare, Inc.: $33,365.22 across 43 records.
- Ionis Pharmaceuticals, Inc.: $4,336.21 across 7 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
25 years (graduated 2001)
CMS Doctors and Clinicians data list 2001 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Smith has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Smith as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Sandy and Utah
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Allergy & Immunology in Utah (2024, 17 clinicians with data). Median for this group: 502. Middle half: 257 to 1,276.
Too few clinicians listed under Allergy & Immunology in Sandy have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Allergy & Immunology in Utah (2024, 17 clinicians with data). Median for this group: $13,232. Middle half: $10,195 to $18,167.
Too few clinicians listed under Allergy & Immunology in Sandy have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Allergy & Immunology in Utah (2024, 17 clinicians with data). Median for this group: $9,194. Middle half: $7,743 to $14,378.
Too few clinicians listed under Allergy & Immunology in Sandy have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 95% of clinicians listed under Allergy & Immunology in Utah (2024, 17 clinicians with data). Median for this group: 305. Middle half: 157 to 449.
Too few clinicians listed under Allergy & Immunology in Sandy have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 90% of clinicians listed under Allergy & Immunology in Utah (2024, 17 clinicians with data). Median for this group: $96,646. Middle half: $65,236 to $221,968.
Too few clinicians listed under Allergy & Immunology in Sandy have Medicare Part D data for 2024 to compare.
2 active clinicians are listed under Allergy & Immunology with a practice address in Sandy, UT (29 in Utah).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 165% from 5,974 in 2020 to 15,834 in 2024.
- 2020: 5,974
- 2021: 8,337
- 2022: 13,718
- 2023: 10,496
- 2024: 15,834
-
Medicare-allowed amount
Medicare-allowed amount increased 365% from $85,673 in 2020 to $398,210 in 2024.
- 2020: $85,673
- 2021: $139,489
- 2022: $305,279
- 2023: $224,686
- 2024: $398,210
-
Paid by Medicare
Paid by Medicare increased 402% from $61,213 in 2020 to $307,209 in 2024.
- 2020: $61,213
- 2021: $100,822
- 2022: $232,141
- 2023: $170,240
- 2024: $307,209
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 44% from 1,084 in 2020 to 1,562 in 2024.
- 2020: 1,084
- 2021: 1,043
- 2022: 1,068
- 2023: 1,310
- 2024: 1,562
-
30-day fills
30-day fills increased 44% from 1,640 in 2020 to 2,356 in 2024.
- 2020: 1,640
- 2021: 1,594
- 2022: 1,650
- 2023: 1,961
- 2024: 2,356
-
Part D drug cost
Part D drug cost increased 176% from $189,455 in 2020 to $523,381 in 2024.
- 2020: $189,455
- 2021: $209,743
- 2022: $239,751
- 2023: $230,504
- 2024: $523,381
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 82% from $80,479.26 in 2021 to $146,097.99 in 2025.
- 2021: $80,479.26
- 2022: $114,364.92
- 2023: $60,030.25
- 2024: $151,882.52
- 2025: $146,097.99
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 323 records totaling $146,097.99.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Pharming Healthcare, Inc. |
Consulting Fee
Cash or cash equivalent
|
RUCONEST | General | $5,535.00 |
| AstraZeneca Pharmaceuticals LP |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
TEZSPIRE | General | $4,720.00 |
| AstraZeneca Pharmaceuticals LP |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
AIRSUPRA | General | $4,720.00 |
| AstraZeneca Pharmaceuticals LP |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
AIRSUPRA | General | $4,720.00 |
| AstraZeneca Pharmaceuticals LP |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
TEZSPIRE | General | $4,720.00 |
| Pharming Healthcare, Inc. |
Consulting Fee
Cash or cash equivalent
|
RUCONEST | General | $4,305.00 |
| Pharming Healthcare, Inc. |
Consulting Fee
Cash or cash equivalent
|
RUCONEST | General | $4,305.00 |
| Pharming Healthcare, Inc. |
Travel and Lodging
In-kind items and services
|
RUCONEST | General | $3,798.78 |
| AstraZeneca Pharmaceuticals LP |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
AIRSUPRA | General | $3,700.00 |
| AstraZeneca Pharmaceuticals LP |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
FASENRA | General | $3,700.00 |
| AstraZeneca Pharmaceuticals LP |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
FASENRA | General | $3,700.00 |
| AstraZeneca Pharmaceuticals LP |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
AIRSUPRA | General | $3,700.00 |
| AstraZeneca Pharmaceuticals LP |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
AIRSUPRA | General | $3,700.00 |
| AstraZeneca Pharmaceuticals LP |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
FASENRA | General | $3,700.00 |
| Pharming Healthcare, Inc. |
Consulting Fee
Cash or cash equivalent
|
RUCONEST | General | $3,075.00 |
| Pharming Healthcare, Inc. |
Consulting Fee
Cash or cash equivalent
|
RUCONEST | General | $3,075.00 |
| AstraZeneca Pharmaceuticals LP |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
AIRSUPRA | General | $2,950.00 |
| AstraZeneca Pharmaceuticals LP |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
AIRSUPRA | General | $2,800.00 |
| AstraZeneca Pharmaceuticals LP |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
FASENRA | General | $2,800.00 |
| AstraZeneca Pharmaceuticals LP |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
AIRSUPRA | General | $2,800.00 |
| Ionis Pharmaceuticals, Inc. |
Consulting Fee
Cash or cash equivalent
|
DAWNZERA | General | $2,780.00 |
| Regeneron Pharmaceuticals, Inc. |
Consulting Fee
Cash or cash equivalent
|
DUPIXENT | General | $2,532.00 |
| AstraZeneca Pharmaceuticals LP |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
AIRSUPRA | General | $2,350.00 |
| AstraZeneca Pharmaceuticals LP |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
AIRSUPRA | General | $2,350.00 |
| AstraZeneca Pharmaceuticals LP |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
AIRSUPRA | General | $2,350.00 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J2357
Injection, omalizumab, 5 mg
|
7,050 | 12 | $97.78 | $33.07 |
|
95165
Professional service for preparation and provision of 1 or more antigens
|
3,960 | 85 | $20.00 | $14.01 |
|
95004
Test for allergy using allergenic extract
|
1,601 | 39 | $8.58 | $3.49 |
|
95117
Professional service for multiple injections of allergen
|
1,399 | 89 | $25.00 | $11.65 |
|
96160
Administration and interpretation of patient-focused health risk assessment
|
491 | 263 | $10.00 | $2.81 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
313 | 188 | $260.04 | $124.28 |
|
94010
Test to measure expiratory airflow and volume
|
277 | 173 | $67.50 | $26.21 |
|
96372
Injection of drug or substance under skin or into muscle
|
182 | 25 | $54.00 | $13.91 |
|
96401
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
|
136 | 13 | $115.00 | $68.53 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
105 | 82 | $183.77 | $87.77 |
|
99457
Management using the results of remote vital sign monitoring per calendar month, first 20 minutes
|
93 | 16 | $120.00 | $47.91 |
|
99458
Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes
|
76 | 15 | $65.00 | $38.72 |
|
99454
Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days
|
65 | 13 | $150.00 | $44.94 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
34 | 34 | $337.59 | $164.01 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
22 | 22 | $222.91 | $105.36 |
|
94060
Test to measure expiratory airflow and volume changes before and after medication administration
|
17 | 17 | $129.82 | $37.27 |
|
99453
Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment
|
13 | 13 | $45.00 | $18.99 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Montelukast Sodium | Montelukast Sodium | 330 | 19,442 | $2,432.61 | 78 |
| Famotidine | Famotidine | 134 | 7,485 | $2,239.23 | 33 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 106 | 4,171 | $1,593.50 | 21 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 98 | 2,042 | $2,136.28 | 66 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 84 | 3,270 | $69,296.52 | 21 |
| Azelastine Hcl | Azelastine Hcl | 67 | 3,480 | $2,642.11 | 31 |
| Zafirlukast | Zafirlukast | 64 | 2,460 | $4,382.83 | 17 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 50 | 1,680 | $6,534.33 | 11 |
| Mometasone Furoate | Mometasone Furoate | 47 | 2,040 | $4,748.90 | 17 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 44 | 1,620 | $34,073.58 | 15 |
| Fluticasone Propionate | Fluticasone Propionate | 42 | 2,710 | $1,020.61 | 13 |
| Cromolyn Sodium | Cromolyn Sodium | 39 | 1,381 | $22,167.27 | 12 |
| Olopatadine Hcl | Olopatadine Hcl | 32 | 1,147 | $3,861.02 | 14 |
| Epinastine Hcl | Epinastine Hcl | 31 | 1,286 | $1,296.92 | 13 |
| Spiriva Respimat | Tiotropium Bromide | 29 | 990 | $17,396.07 | — |
| Xolair | Omalizumab | 26 | 728 | $70,150.93 | — |
| Azelastine-Fluticasone | Azelastine/Fluticasone | 25 | 841 | $3,015.47 | 15 |
| Ipratropium Bromide | Ipratropium Bromide | 24 | 1,004 | $793.15 | — |
| Cimetidine | Cimetidine | 23 | 1,110 | $2,592.86 | — |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 23 | 745 | $388.94 | — |
| Epinephrine | Epinephrine | 23 | 290 | $4,788.93 | 19 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 19 | 630 | $4,141.72 | — |
| Breyna | Budesonide/Formoterol Fumarate | 19 | 570 | $2,878.98 | — |
| Prednisone | Prednisone | 18 | 95 | $30.67 | 16 |
| Dulera | Mometasone/Formoterol | 17 | 1,050 | $11,813.62 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2024-10-14NUCC Taxonomy Code: 207K00000X
An allergist-immunologist is trained in evaluation, physical and laboratory diagnosis, and management of disorders involving the immune system. Selected examples of such conditions include asthma, anaphylaxis, rhinitis, eczema, and adverse reactions to drugs, foods, and insect stings as well as immune deficiency diseases (both acquired and congenital), defects in host defense, and problems related to autoimmune disease, organ transplantation, or malignancies of the immune system.
NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - ALLERGY/IMMUNOLOGY
I20141124000489
UT
0648236679
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Allergy Associates Of Utah Pc
7390 S Creek Rd, Sandy, UT 840936123
Phone: 8012638700
Allergy Associates Of Utah Pc
6095 S Fashion Blvd, Murray, UT 841077377
Phone: 8012638700
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Physician Assistant - Surgical
Physician Assistant (Certified)
Allergy & Immunology
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 7390 S CREEK RD STE 201, SANDY, UT 840936123 (Tel: 8012638700)
Internal Medicine (license number reported to NPPES: OH 35084855)
NPI status registered as active in NPPES database
Registered at 6095 S FASHION BLVD STE 100, MURRAY, UT 841077377 (Tel: (801) 263-8700)
Registered at 6095 S FASHION BLVD STE 100, MURRAY, UT 841077377 (Tel: (801) 263-8700)
Recorded as ANDREW SMITH, MD
Allergy & Immunology (license number reported to NPPES: UT 8771272-1205)
NPI status registered as active in NPPES database
Registered at 8444 WINTON RD, CINCINNATI, OH 452314927 (Tel: 5139310775)
Registered at 3255 EDEN AVE, HPB 350, ML 0563, CINCINNATI, OH 452670563 (Tel: 5135584701)
Recorded as ANDREW SMITH, MD
Internal Medicine (license number reported to NPPES: OH 35084855)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Mailing Address
6095 S Fashion Blvd Ste 100
Murray, UT 841077377
Phone: 8012638700